Friday, February 05, 2021 8:25:33 AM
Recent TTOO News
- T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024 • GlobeNewswire Inc. • 04/24/2024 01:00:00 PM
- T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity • GlobeNewswire Inc. • 04/11/2024 08:05:00 PM
- T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. • GlobeNewswire Inc. • 03/28/2024 01:00:00 PM
- T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates • GlobeNewswire Inc. • 03/20/2024 11:30:00 AM
- T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates • GlobeNewswire Inc. • 03/19/2024 01:00:00 PM
- T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel • GlobeNewswire Inc. • 03/18/2024 01:00:00 PM
- T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement • GlobeNewswire Inc. • 03/12/2024 01:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 09:34:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:31:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:30:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:30:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:00:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:00:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:17:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:00:04 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/15/2024 09:49:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:47:41 PM
- T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/15/2024 09:06:00 PM
- T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity • GlobeNewswire Inc. • 02/15/2024 09:04:00 PM
- T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia • GlobeNewswire Inc. • 02/15/2024 09:02:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:15:02 AM
- T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel • GlobeNewswire Inc. • 02/12/2024 02:00:00 PM
- T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024 • GlobeNewswire Inc. • 02/07/2024 09:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM